Allianz Asset Management
QTTB icon

Allianz Asset Management’s Q32 Bio QTTB Stock Holding History

Allianz Asset Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-644
Closed -$131K – 2313
2020
Q4 		$131K Sell
644
-948
-60% -$183K ﹤0.01% 1817
2020
Q3 		$307K Sell
1,592
-1,120
-41% -$251K ﹤0.01% 1708
2020
Q2 		$742K Sell
2,712
-1,998
-42% -$533K ﹤0.01% 1921
2020
Q1 		$1.32M Buy
4,710
+198
+4% +$60.6K ﹤0.01% 1668
2019
Q4 		$1.68M Buy
4,512
+2,757
+157% +$790K ﹤0.01% 1950
2019
Q3 		$572K Buy
+1,755
New +$597K ﹤0.01% 2332

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Allianz Asset Management's QTTB Position: Q1 2021 in Review

Allianz Asset Management sold out of Q32 Bio (QTTB) in Q1 2021, closing a stake of 644 shares — an estimated $131K sold.

Allianz Asset Management first reported a position in QTTB in Q3 2019 and held it in 6 quarters. The position peaked at $1.68M in Q4 2019. 109 funds tracked by Wall St. Rank hold QTTB as of Q1 2021.

  • Allianz Asset Management reported no remaining Q32 Bio position as of Q1 2021 after selling out during the quarter.
  • Allianz Asset Management sold 644 Q32 Bio shares in Q1 2021, an estimated $131K.
  • Allianz Asset Management first reported a position in Q32 Bio in Q3 2019 and held it in 6 quarters.
  • Allianz Asset Management's Q32 Bio position peaked at $1.68M in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2021.

Based on Allianz Asset Management's 13F filing for Q1 2021, filed 13 May 2021.